Pulmotect announced it raised $10.3 Million in an initial filing
Sep 09, 2024•over 1 year ago
Amount Raised
$10.3 Million
HoustonBiotechnology
Company Information
Company
Pulmotect
Location
3900 ESSEX LANE
Houston, Texas, United States
About
Pulmotect has developed PUL-042, an inhaled therapeutic which aims to boost the body's innate immune system resulting in highly-targeted lung protection against all major classes of pathogens including bacteria, fungi, and viral pathogens.
Related People
2 contacts
Sign in to view contact details
Sign in to view contact details
Funding Insights
Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech
Houston